NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.

IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. Some Drugs and Herbal Products. Lyon (FR): International Agency for Research on Cancer; 2016. (IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, No. 108.)

Cover of Some Drugs and Herbal Products

Some Drugs and Herbal Products.

Show details

References

  • Ahlawat KS, Khatkar BS. Processing, food applications and safety of aloe vera products: a review. J Food Sci Technol. 2011;48(5):525–33. [PMC free article: PMC3551117] [PubMed: 23572784] [CrossRef]
  • AHP; American Herbal Pharmacopoeia (2012). Aloe Vera Leaf, Aloe Vera Leaf Juice, Aloe Vera Inner Leaf Juice. Scotts Valley (CA): American Herbal Pharmacopoeia.
  • Akao T, Che Q-M, Kobashi K, Hattori M, Namba T. A purgative action of barbaloin is induced by Eubacterium sp. strain BAR, a human intestinal anaerobe, capable of transforming barbaloin to aloe-emodin anthrone. Biol Pharm Bull. 1996;19(1):136–8. [PubMed: 8820926] [CrossRef]
  • Azaroual L, Liazid A, Barbero GF, Brigui J, Palma M, Barroso CG. Improved chromatographic methods for determination of bioactive compounds from Aloe vera leaves. ISRN Chromatography. 2012;2012:1–7. [CrossRef]
  • Boudreau MD, Beland FA. An evaluation of the biological and toxicological properties of Aloe barbadensis (miller), Aloe vera. J Environ Sci Health C Environ Carcinog Ecotoxicol Rev. 2006;24(1):103–54. [PubMed: 16690538] [CrossRef]
  • Boudreau MD, Beland FA, Nichols JA, Pogribna M. Toxicology and carcinogenesis studies of a noncolorized whole leaf extract of Aloe barbadensis Miller (Aloe vera) in F344/N rats and B6C3F1 mice (drinking water study). Natl Toxicol Program Tech Rep Ser. 2013;577(577):1–266. a. [PubMed: 24042237]
  • Boudreau MD, Mellick PW, Olson GR, Felton RP, Thorn BT, Beland FA. Clear evidence of carcinogenic activity by a whole-leaf extract of Aloe barbadensis miller (aloe vera) in F344/N rats. Toxicol Sci. 2013;131(1):26–39. b. [PMC free article: PMC3537128] [PubMed: 22968693] [CrossRef]
  • Brandin H, Viitanen E, Myrberg O, Arvidsson A-K. Effects of herbal medicinal products and food supplements on induction of CYP1A2, CYP3A4 and MDR1 in the human colon carcinoma cell line LS180. Phytother Res. 2007;21(3):239–44. [PubMed: 17163579] [CrossRef]
  • Brown JP, Dietrich PS. Mutagenicity of anthraquinone and benzanthrone derivatives in the Salmonella/microsome test: activation of anthraquinone glycosides by enzymic extracts of rat cecal bacteria. Mutat Res. 1979;66(1):9–24. [PubMed: 370585] [CrossRef]
  • Brown JP, Dietrich PS, Brown RJ. Frameshift mutagenicity of certain naturally occurring phenolic compounds in the ‘Salmonella/microsome’ test: activation of anthraquinone and flavonol glycosides by gut bacterial enzymes [proceedings]. Biochem Soc Trans. 1977;5(5):1489–92. [PubMed: 336434]
  • Brusick D, Mengs U. Assessment of the genotoxic risk from laxative senna products. Environ Mol Mutagen. 1997;29(1):1–9. [PubMed: 9020301] [CrossRef]
  • Channe Gowda D, Neelisiddaiah B, Anjaneyalu YV. Structural studies of polysaccharides from Aloe vera. Carbohydr Res. 1979;72:201–5. [CrossRef]
  • Che Q-M, Akao T, Hattori M, Kobashi K, Namba T. Isolation of a human intestinal bacterium capable of transforming barbaloin to aloe-emodin anthrone. Planta Med. 1991;57(1):15–9. [PubMed: 2062951] [CrossRef]
  • Chen Y-Y, Chiang S-Y, Lin J-G, Yang JS, Ma YS, Liao CL, et al. Emodin, aloe-emodin and rhein induced DNA damage and inhibited DNA repair gene expression in SCC-4 human tongue cancer cells. Anticancer Res. 2010;30(3):945–51. [PubMed: 20393018]
  • Chiu T-H, Lai W-W, Hsia T-C, Yang JS, Lai TY, Wu PP, et al. Aloe-emodin induces cell death through S-phase arrest and caspase-dependent pathways in human tongue squamous cancer SCC-4 cells. Anticancer Res. 2009;29(11):4503–11. [PubMed: 20032398]
  • Committee of Experts on Cosmetic Products (2008). Aloe extracts with anthraquinones. Active ingredients used in cosmetics: safety survey. Strasbourg, France: Council of Europe Publishing; pp. 9–27.
  • Cosmetic Ingredient Review Expert Panel. Final report on the safety assessment of AloeAndongensis Extract, Aloe Andongensis Leaf Juice,aloe Arborescens Leaf Extract, Aloe Arborescens Leaf Juice, Aloe Arborescens Leaf Protoplasts, Aloe Barbadensis Flower Extract, Aloe Barbadensis Leaf, Aloe Barbadensis Leaf Extract, Aloe Barbadensis Leaf Juice,aloe Barbadensis Leaf Polysaccharides, Aloe Barbadensis Leaf Water, Aloe Ferox Leaf Extract, Aloe Ferox Leaf Juice, and Aloe Ferox Leaf Juice Extract. Int J Toxicol. 2007;26(1) Suppl 2:1–50. [PubMed: 17613130] [CrossRef]
  • Dal’Belo SE, Gaspar LR, Maia Campos PM. Moisturizing effect of cosmetic formulations containing Aloe vera extract in different concentrations assessed by skin bioengineering techniques. Skin Res Technol. 2006;12(4):241–6. [PubMed: 17026654] [CrossRef]
  • Davis B, Goux WJ. Single-laboratory validation of an NMR method for the determination of aloe vera polysaccharide in pharmaceutical formulations. J AOAC Int. 2009;92(6):1607–16. [PubMed: 20166576]
  • De Witte P, Lemli J. Excretion and distribution of [14C]rhein and [14C]rhein anthrone in rat. J Pharm Pharmacol. 1988;40(9):652–5. [PubMed: 2907037] [CrossRef]
  • Dentali S. “Nondecolorized” essential qualifier for NTP aloe vera study material. Toxicol Sci. 2013;133(2):342. [PubMed: 23492813] [CrossRef]
  • Djuv A, Nilsen OG. Aloe vera juice: IC₅₀ and dual mechanistic inhibition of CYP3A4 and CYP2D6. Phytother Res. 2012;26(3):445–51. [PubMed: 21842479]
  • Dreessen M, Lemli J. Studies in the field of drugs containing anthraquinone derivatives. XXXVI. The metabolism of cascarosides by intestinal bacteria. Pharm Acta Helv. 1988;63(9-10):287–9. [PubMed: 3237734]
  • Duke JA, Beckstrom-Sternberg SM. “Acceptable” Levels of Flavoring Ingredients? Developmental Food Science. 1994;34:741–757.
  • Elsohly MA, Gul W, Avula B, Khan IA. Determination of the anthraquinones aloe-emodin and aloin-A by liquid chromatography with mass spectrometric and diode array detection. J AOAC Int. 2007;90(1):28–42. [PubMed: 17373434]
  • EMA (2006). Community herbal monograph on Aloe barbadensis MILLER and on Aloe (various species, mainly Aloe ferox MILLER and its hybrids). London, UK: European Medicines Agency.
  • Eur Ph; European Pharmacopoeia (2008). European pharmacopoeia. 7.0. Strasbourg, France: European Directorate for the Quality of Medicines & HealthCare.
  • FDA, Food and Drug Administration. Status of certain additional over-the-counter drug category II and III active ingredients. Final rule. Fed Regist. 2002;67(90):31125–7. http://www​.fda.gov/downloads​/Drugs/DevelopmentApprovalProcess​/DevelopmentResources​/Over-the-CounterOTCDrugs​/StatusofOTCRulemakings​/ucm094018.pdf [PubMed: 12001972]
  • Femenia A, Sanchez E, Simal S, Rosselló C. Compositional features of polysacchardies from Aloe vera (Aloe barbadensis Miller) plant tissues. Carbohydr Polym. 1999;39(2):109–17. [CrossRef]
  • Fogleman RW, Shellenberger TE, Balmer MF, Carpenter RH, McAnalley BH. Subchronic oral administration of acemannan in the rat and dog. Vet Hum Toxicol. 1992;34(2):144–7. [PubMed: 1509675]
  • Geisser J, Kratz E. Determination of Aloe vera gel in cosmetics. CBS Camag Bibliography Service. 2010;104:13–15.
  • GRIN; Germplasm Resources Information Network (2013). National Germplasm Resources Laboratory, Beltsville (Md): USDA. Available from: http://www​.ars-grin.gov​/cgi-bin/npgs/html/genform.pl, accessed 5 June 2013.
  • Grindlay D, Reynolds T. The Aloe vera phenomenon: a review of the properties and modern uses of the leaf parenchyma gel. J Ethnopharmacol. 1986;16(2-3):117–51. [PubMed: 3528673] [CrossRef]
  • Groom QJ, Reynolds T. Barbaloin in aloe species. Planta Med. 1987;53(4):345–8. [PubMed: 17269040] [CrossRef]
  • Hamman JH. Composition and applications of Aloe vera leaf gel. Molecules. 2008;13(8):1599–616. [PMC free article: PMC6245421] [PubMed: 18794775] [CrossRef]
  • Hattori M, Akao T, Kobashi K, Namba T. Cleavages of the O- and C-glucosyl bonds of anthrone and 10,10′-bianthrone derivatives by human intestinal bacteria. Pharmacology. 1993;47 Suppl 1:125–33. [PubMed: 8234419] [CrossRef]
  • Hattori M, Kanda T, Shu Y-Z, Akao T, Kobashi K, Namba T. Metabolism of barbaloin by intestinal bacteria. Chem Pharm Bull (Tokyo). 1988;36(11):4462–6. [PubMed: 3246014] [CrossRef]
  • Heidemann A, Völkner W, Mengs U. Genotoxicity of aloeemodin in vitro and in vivo. Mutat Res. 1996;367(3):123–33. [PubMed: 8600368] [CrossRef]
  • Herlihy JT, Bertrand HA, Kim JD, Ikeno Y, Yu BP. Effects of Aloe vera ingestion in the rat I. Growth, food and fluid intake and serum chemistry. Phytother Res. 1998;12(3):183–8. [CrossRef]
  • Hirata T, Sakano S, Suga T. Biotransformation of aloenin, a bitter glucoside constituent of Aloe arborescens, by rats. Experientia. 1981;37(12):1252–3. [PubMed: 7035211] [CrossRef]
  • Hsia T-C, Yang J-S, Chen G-W, Chiu TH, Lu HF, Yang MD, et al. The roles of endoplasmic reticulum stress and Ca2+ on rhein-induced apoptosis in A-549 human lung cancer cells. Anticancer Res. 2009;29(1):309–18. [PubMed: 19331167]
  • IASC (2009). IASC Labeling Guidance. Silver Spring (MD): International Aloe Science Council. Available from: http://www​.iasc.org/pdfs​/10_0405_IASC_Labeling​_Guidance_Definitions.pdf.
  • IASC (2013a). The nomenclature of Aloe vera. Silver Spring (MD): International Aloe Science Council. Available from: http://www​.iasc.org/Aloe_Taxonomy.pdf, accessed 3 June 2014.
  • IASC (2013b). Aloe vera quality standard. Silver Spring (MD), USA: International Aloe Science Council. Available from: http://iasc​.org/pdfs​/AloeVeraQualityStandard.pdf, accessed 3 June 2014.
  • Ikeno Y, Hubbard GB, Lee S, Yu BP, Herlihy JT. The influence of long-term Aloe vera ingestion on age-related disease in male Fischer 344 rats. Phytother Res. 2002;16(8):712–8. [PubMed: 12458471] [CrossRef]
  • IMS Health (2012). Multinational Integrated Data Analysis (MIDAS). Worldwide Sales of Selected Products. Plymouth Meeting, Pennsylvania: IMS Health.
  • Ishii Y, Tanizawa H, Takino Y. Determination of barbaloin in rat serum. Chem Pharm Bull (Tokyo). 1987;35(11):4642–4. [PubMed: 3442898] [CrossRef]
  • Jiao P, Jia Q, Randel G, Diehl B, Weaver S, Milligan G. Quantitative 1H-NMR spectrometry method for quality control of Aloe vera products. J AOAC Int. 2010;93(3):842–8. [PubMed: 20629385]
  • Joseph B, Raj SJ. Pharmacognostic and phytochemical properties of Aloe vera Linn−an overview. International Journal of Pharmaceutical Sciences Review and Research. 2010;4:106–110.
  • JP XVI, The Japanese Pharmacopoeia (2011). The Japanese Pharmacopoeia. 16th ed. English Version, Tokyo, Japan: Ministry of Health, Labour and Welfare.
  • Kim KH, Park JH (2006). Quality control and standardization of Aloe products. In: Park YI, Lee SK, editors. New Perspectives on Aloe. New York (NY), USA: Springer Science and Business Media; pp. 169–189.
  • Kratz E. Aloe vera. Evidence of active content. Cossma. 2009;10:12–13.
  • Kuzuya H, Shimpo K, Beppu H (2004). Aloe lectins and their activities. In: Reynolds T, editor. Aloes: The genus Aloe. 38th ed. Boca Raton (FL), USA: CRC Press; pp. 88–110.
  • Lachenmeier K, Kuepper U, Musshoff F, et al. Quality control of Aloe vera beverages. Electronic Journal of Environmental, Agricultural and Food Chemistry. 2005;4:1033–1042.
  • Lai W-W, Yang J-S, Lai K-C, Kuo CL, Hsu CK, Wang CK, et al. Rhein induced apoptosis through the endoplasmic reticulum stress, caspase- and mitochondria-dependent pathways in SCC-4 human tongue squamous cancer cells. In Vivo. 2009;23(2):309–16. [PubMed: 19414420]
  • Lang W. Pharmacokinetic-metabolic studies with 14C-aloe emodin after oral administration to male and female rats. Pharmacology. 1993;47 Suppl 1:110–9. [PubMed: 8234417] [CrossRef]
  • Lee S, Do SG, Kim SY, Kim J, Jin Y, Lee CH. Mass spectrometry-based metabolite profiling and antioxidant activity of Aloe vera ( Aloe barbadensis Miller) in different growth stages. J Agric Food Chem. 2012;60(45):11222–8. [PubMed: 23050594] [CrossRef]
  • Leon L. The medicinal plant Aloe. Ganzheitliche Tiermedizin. 2003;17:138–143.
  • Lin M-L, Chen S-S, Lu Y-C, Liang RY, Ho YT, Yang CY, et al. Rhein induces apoptosis through induction of endoplasmic reticulum stress and Ca2+-dependent mitochondrial death pathway in human nasopharyngeal carcinoma cells. Anticancer Res. 2007;27 5A:3313–22. [PubMed: 17970076]
  • Lin M-L, Lu Y-C, Chung J-G, Li YC, Wang SG, N G SH, et al. Aloe-emodin induces apoptosis of human nasopharyngeal carcinoma cells via caspase-8-mediated activation of the mitochondrial death pathway. Cancer Lett. 2010;291(1):46–58. [PubMed: 19942342] [CrossRef]
  • Mandal G, Das A. Structure of the D-galactan isolated from Aloe barbadensis Miller. Carbohydr Res. 1980;86(2):247–57. [CrossRef]
  • Mandrioli R, Mercolini L, Ferranti A, Fanali S, Raggi MA. Determination of aloe emodin in Aloe vera extracts and commercial formulations by HPLC with tandem UV absorption and fluorescence detection. Food Chem. 2011;126(1):387–93. [CrossRef]
  • Matsuda Y, Yokohira M, Suzuki S, Hosokawa K, Yamakawa K, Zeng Y, et al. One-year chronic toxicity study of Aloe arborescens Miller var. natalensis Berger in Wistar Hannover rats. A pilot study. Food Chem Toxicol. 2008;46(2):733–9. [PubMed: 17981383] [CrossRef]
  • Morgan M, Bone K, Mills S et al. (2005). Aloe. Safety monograph. In: Mills S, Bone K, editors. The essential guide to herbal safety. St. Louis (MO), USA: Elsevier Churchill Livingstone; pp. 233–240.
  • Morimoto I, Watanabe F, Osawa T, Okitsu T, Kada T. Mutagenicity screening of crude drugs with Bacillus subtilis rec-assay and Salmonella/microsome reversion assay. Mutat Res. 1982;97(2):81–102. [PubMed: 6804865] [CrossRef]
  • Müller SO, Stopper H. Characterization of the genotoxicity of anthraquinones in mammalian cells. Biochim Biophys Acta. 1999;1428(2-3):406–14. [PubMed: 10434060] [CrossRef]
  • Müller SO, Eckert I, Lutz WK, Stopper H. Genotoxicity of the laxative drug components emodin, aloe-emodin and danthron in mammalian cells: topoisomerase II mediated? Mutat Res. 1996;371(3-4):165–73. [PubMed: 9008718] [CrossRef]
  • NCCAM (2012). Aloe vera. Bethesda (MD): National Center for Complementary and Alternative Medicine. Available from: http://nccam​.nih.gov/health/aloevera, accessed 5 June 2014.
  • Nesslany F, Simar-Meintières S, Ficheux H, Marzin D. Aloe-emodin-induced DNA fragmentation in the mouse in vivo comet assay. Mutat Res. 2009;678(1):13–9. [PubMed: 19559101] [CrossRef]
  • Newton LE (2004). Aloes in habitat. In: Reynolds T, editor. Aloes: the genus Aloe. Boca Raton (FL), USA: CRC Press; pp. 3–14.
  • Ngo MQ, Nguyen NN, Shah SA. Oral aloe vera for treatment of diabetes mellitus and dyslipidemia. Am J Health Syst Pharm. 2010;67(21):1804–11, 1806, 1808 passim. [PubMed: 20966143] [CrossRef]
  • NHANES (2010). National Health and Nutrition Examination Survey (1999–2010). Atlanta (GA): Centers for Disease Control and Prevention. Available from: http://www​.cdc.gov/nchs/nhanes.htm; accessed 5 June 2014.
  • Ni Y, Turner D, Yates KM, Tizard I. Isolation and characterization of structural components of Aloe vera L. leaf pulp. Int Immunopharmacol. 2004;4(14):1745–55. [PubMed: 15531291] [CrossRef]
  • NLM (2012). Products that contain active ingredient - Aloe vera. Dietary supplements labels database. United States National Library of Medicine. Available from: http://www​.dsld.nlm.nih.gov/dsld/; accessed 5 June 2014.
  • NTP. National Toxicology Program. Photocarcinogenesis study of aloe vera [CAS NO. 481–72–1(Aloe-emodin)] in SKH-1 mice (simulated solar light and topical application study). Natl Toxicol Program Tech Rep Ser. 2010;553(553):7–33, 35–97, 99–103 passim. [PubMed: 21031007]
  • Nutrition Business Journal (2010). NBJ’s Supplement Business Report. An analysis of markets, trends, competition and strategy in the U.S. dietary supplement industry. New York (NY), USA: Penton Media, Inc.
  • Nutrition Business Journal (2012). NBJ’s Supplement Business Report. An analysis of markets, trends, competition and strategy in the U.S. dietary supplement industry. . New York (NY), USA: Penton Media, Inc. Available from: http://newhope360​.com​/2012-supplement-business-report; accessed 5 June 2014.
  • O’Neil MJ, Heckelman PE, Koch CB et al. (2006). The Merck Index - An Encyclopedia of Chemicals, Drugs, and Biologicals. 14th Ed. Version 14.6. Whitehouse Station (NJ), USA: Merck & Co., Inc.
  • Okamura N, Asai M, Hine N, Yagi A. High-performance liquid chromatographic determination of phenolic compounds in Aloe species. J Chromatogr A. 1996;746(2):225–31. [CrossRef]
  • Paes-Leme AA, Motta ES, De Mattos JCP, Dantas FJ, Bezerra RJ, Caldeira-de-Araujo A. Assessment of Aloe vera (L.) genotoxic potential on Escherichia coli and plasmid DNA. J Ethnopharmacol. 2005;102(2):197–201. [PubMed: 16054315] [CrossRef]
  • Paez A, Michael Gebre G, Gonzalez ME, Tschaplinski TJ. Growth, soluble carbohydrates, and aloin concentration of Aloe vera plants exposed to three irradiance levels. Environ Exp Bot. 2000;44(2):133–9. [PubMed: 10996366] [CrossRef]
  • Pandiri AR, Sills RC, Hoenerhoff MJ, Peddada SD, Ton TV, Hong HH, et al. Aloe vera non-decolorized whole leaf extract-induced large intestinal tumors in F344 rats share similar molecular pathways with human sporadic colorectal tumors. Toxicol Pathol. 2011;39(7):1065–74. [PMC free article: PMC4911224] [PubMed: 21937742] [CrossRef]
  • Park MK, Park JH, Kim NY, Shin YG, Choi YS, Lee JG, et al. Analysis of 13 phenolic compounds in Aloe species by high performance liquid chromatography. Phytochem Anal. 1998;9(4):186–91. [CrossRef]
  • Park YI, Jo TH (2006). Perspectives of industrial application of Aloe vera. In: Park YI, Lee SK, editors. New Perspectives on Aloe. New York (NY), USA: Springer Science+Business Media; pp. 191–200.
  • Pelley RP, Martini WJ, Liu DQ, et al. Multiparameter analysis of commercial “Aloe vera” materials and comparison to Aloe barbadensis Miller extracts. Subtropical Plant Science. 1998;50:1–14.
  • Pellizzoni M, Molinari GP, Lucini L. Stability of the main Aloe fractions and Aloe-based commercial products under different storage conditions. Agrochimica. 2011;5:288–296.
  • Perkins SL, Livesey JF. A rapid high-performance thin-layer chromatographic urine screen for laxative abuse. Clin Biochem. 1993;26(3):179–81. [PubMed: 8330386] [CrossRef]
  • Pogribna M, Freeman JP, Paine D, Boudreau MD. Effect of Aloe vera whole leaf extract on short chain fatty acids production by Bacteroides fragilis, Bifidobacterium infantis and Eubacterium limosum. Lett Appl Microbiol. 2008;46(5):575–80. [PubMed: 18363656] [CrossRef]
  • Ramachandra CT, Rao PS. Processing of Aloe vera leaf gel: a review. Am J Agric Biol Sci. 2008;3(2):502–10. [CrossRef]
  • Ramírez Durón R, Ceniceros Almaguer L, Cavazos Rocha NC, Silva Flores PG, De Torres NW. Comparison of high-performance liquid chromatographic and thin-layer chromatographic methods for determination of aloin in herbal products containing Aloe vera. J AOAC Int. 2008;91(6):1265–70. [PubMed: 19202785]
  • Reynolds T (2004). Aloe chemistry. In: Reynolds T, editor. Aloes: The genus Aloe. 38th Ed. Boca Raton (FL), USA: CRC Press; pp. 39–74.
  • Rodríguez ER, Martín JD, Romero CD. Aloe vera as a functional ingredient in foods. Crit Rev Food Sci Nutr. 2010;50(4):305–26. [PubMed: 20301017] [CrossRef]
  • Saccù D, Bogoni P, Procida G. Aloe exudate: characterization by reversed phase HPLC and headspace GC-MS. J Agric Food Chem. 2001;49(10):4526–30. [PubMed: 11599983] [CrossRef]
  • SciFinder (2013). CAS Registry Number 8001–97–6. Columbus (OH). USA: Chemical Abstracts Service, American Chemical Society. Accessed: 15 January 2013.
  • Sehgal I, Winters WD, Scott M, David A, Gillis G, Stoufflet T, et al. 2013bToxicologic assessment of a commercial decolorized whole leaf aloe vera juice, lily of the desert filtered whole leaf juice with aloesorb. J ToxicolEpub802453.10.1155/2013/802453. [PMC free article: PMC3608129] [PubMed: 23554812] [CrossRef]
  • Sehgal I, Winters WD, Scott M, Kousoulas K. An in vitro and in vivo toxicologic evaluation of a stabilized aloe vera gel supplement drink in mice. Food Chem Toxicol. 2013;55:363–70. [PubMed: 23376510] [CrossRef]
  • Sehgal I, Winters WD, Scott M, Kousoulas K. An in vitro and in vivo toxicologic evaluation of a stabilized aloe vera gel supplement drink in mice. Food Chem Toxicol. 2013;55:363–70. a. [PubMed: 23376510] [CrossRef]
  • Shah AH, Qureshi S, Tariq M, Ageel M. Toxicity studies on six plants used in the traditional Arab system of medicine. Phytother Res. 1989;3(1):25–9. [CrossRef]
  • Shao A, Broadmeadow A, Goddard G, Bejar E, Frankos V. Safety of purified decolorized (low anthraquinone) whole leaf Aloe vera (L) Burm. f. juice in a 3-month drinking water toxicity study in F344 rats. Food Chem Toxicol. 2013;57:21–31. [PubMed: 23500775] [CrossRef]
  • Spohn R (2013). Water colour of Aloe vera. Available from: http://www​.spohns.de​/heilpflanzenillus/aloevera.html; accessed 28 May 2014.
  • Steenkamp V, Stewart MJ. Medicinal applications and toxicological activities of Aloe products. Pharmaceutical Biology. 2007;45(5):411–20. [CrossRef]
  • Stolk LM, Hoogtanders K. Detection of laxative abuse by urine analysis with HPLC and diode array detection. Pharm World Sci. 1999;21(1):40–3. [PubMed: 10214668] [CrossRef]
  • Tang JC, Yang H, Song XY, Song XH, Yan SL, Shao JQ, et al. Inhibition of cytochrome P450 enzymes by rhein in rat liver microsomes. Phytother Res. 2009;23(2):159–64. [PubMed: 18814214] [CrossRef]
  • Turner CE, Williamson DA, Stroud PA, Talley DJ. Evaluation and comparison of commercially available Aloe vera L. products using size exclusion chromatography with refractive index and multi-angle laser light scattering detection. Int Immunopharmacol. 2004;4(14):1727–37. [PubMed: 15531289] [CrossRef]
  • Ulbricht C, Armstrong J, Basch E, Basch S, Bent S, Dacey C, et al. An evidence-based systematic review of Aloe vera by the natural standard research collaboration. J Herb Pharmacother. 2007;7(3-4):279–323. [PubMed: 18928148] [CrossRef]
  • Vogler BK, Ernst E. Aloe vera: a systematic review of its clinical effectiveness. Br J Gen Pract. 1999;49(447):823–8. [PMC free article: PMC1313538] [PubMed: 10885091]
  • Vyth A, Kamp PE. Detection of anthraquinone laxatives in the urine. Pharm Weekbl. 1979;1(1):456–9. [CrossRef]
  • Waller TA, Pelley RP, Strickland FM (2004). Industrial processing and quality control of Aloe barbadensis (Aloe vera) gel. In: Reynolds T, editor. Aloes: The genus Aloe. 38th Ed. Boca Raton (FL), USA: CRC Press; pp. 139–205.
  • Westendorf J, Marquardt H, Poginsky B, Dominiak M, Schmidt J, Marquardt H. Genotoxicity of naturally occurring hydroxyanthraquinones. Mutat Res. 1990;240(1):1–12. [PubMed: 2294411] [CrossRef]
  • WHO (1999). Aloe and Aloe vera gel. WHO Monographs on selected medicinal plants. Vol. 1. Geneva, Switzerland: World Health Organization; pp. 33–49 (available from http://apps​.who.int/medicinedocs​/en/d/Js2200e/5.html)
  • Williams LD, Burdock GA, Shin E, Kim S, Jo TH, Jones KN, et al. Safety studies conducted on a proprietary high-purity aloe vera inner leaf fillet preparation, Qmatrix. Regul Toxicol Pharmacol. 2010;57(1):90–8. [PubMed: 20096744] [CrossRef]
  • Wölfle D, Schmutte C, Westendorf J, Marquardt H. Hydroxyanthraquinones as tumor promoters: enhancement of malignant transformation of C3H mouse fibroblasts and growth stimulation of primary rat hepatocytes. Cancer Res. 1990;50(20):6540–4. [PubMed: 2208114]
  • Yagi A, Nakamori J, Yamada T, Iwase H, Tanaka T, Kaneo Y, et al. In vivo metabolism of aloemannan. Planta Med. 1999;65(5):417–20. [PubMed: 10418327] [CrossRef]
  • Yaron A. Characterization of Aloe vera gel before and after autodegradation, and stabilization of the natural fresh gel. Phytother Res. 1993;7(7):11. [CrossRef]
  • Yokohira M, Matsuda Y, Suzuki S, Hosokawa K, Yamakawa K, Hashimoto N, et al. Equivocal colonic carcinogenicity of Aloe arborescens Miller var. natalensis berger at high-dose level in a Wistar Hannover rat 2-y study. J Food Sci. 2009;74(2):T24–30. [PubMed: 19323775] [CrossRef]
  • Zaffaroni M, Mucignat C, Pecere T, Zagotto G, Frapolli R, D’Incalci M, et al. High-performance liquid chromatographic assay for the determination of Aloe Emodin in mouse plasma. J Chromatogr B Analyt Technol Biomed Life Sci. 2003;796(1):113–9. [PubMed: 14552822] [CrossRef]
© International Agency for Research on Cancer, 2016. For more information contact publications@iarc.fr.
Bookshelf ID: NBK350464

Views

  • PubReader
  • Print View
  • Cite this Page
  • PDF version of this title (8.9M)

Related information

  • PMC
    PubMed Central citations
  • PubMed
    Links to PubMed

Recent Activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...